Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lerman

Showing results (221-230 of 245) with videos related to

Pageof 25
Sort By:
Journal of Applied Behavior Analysis|December 2, 2010
Applying signal-detection theory to the study of observer accuracy and bias in behavioral assessmentDorothea C Lerman, Allison Tetreault, Alyson Hovanetz, et al.
Cancer Genetics and Cytogenetics|March 24, 1999
An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancerH T Lynch, P Watson, S Tinley, et al.
Molecular Psychiatry|December 10, 2008
Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotypeJ Loughead, E P Wileyto, J N Valdez, et al.
Intellectual and Developmental Disabilities|December 1, 2022
Preliminary Results of an Interdisciplinary Behavioral Program to Improve Access to Preventative Dental Care for Adults With Intellectual and Developmental DisabilitiesJohn C Berens, Loukia Tsami, Dorothea C Lerman, et al.
Preventive Medicine|July 18, 2000
Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testingC Lerman, C Hughes, R T Croyle, et al.
The Pharmacogenomics Journal|August 3, 2011
Gender-stratified gene and gene-treatment interactions in smoking cessationW Lee, A W Bergen, G E Swan, et al.
The Pharmacogenomics Journal|March 10, 2004
The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trialC Lerman, E P Wileyto, F Patterson, et al.
Clinical Pharmacology and Therapeutics|April 5, 2008
Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropionF Patterson, R A Schnoll, E P Wileyto, et al.
Journal of the National Cancer Institute|July 3, 1996
A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testingJ R Botkin, R T Croyle, K R Smith, et al.
Cancer|January 12, 2000
Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Part II: Hereditary nonpolyposis colorectal carcinoma as a modelH T Lynch, P Watson, T G Shaw, et al.
Pageof 25

Showing results (221-230 of 245) with videos related to

Sort By:
Pageof 25
Journal of Applied Behavior Analysis|December 2, 2010
Applying signal-detection theory to the study of observer accuracy and bias in behavioral assessmentDorothea C Lerman, Allison Tetreault, Alyson Hovanetz, et al.
Cancer Genetics and Cytogenetics|March 24, 1999
An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancerH T Lynch, P Watson, S Tinley, et al.
Molecular Psychiatry|December 10, 2008
Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotypeJ Loughead, E P Wileyto, J N Valdez, et al.
Intellectual and Developmental Disabilities|December 1, 2022
Preliminary Results of an Interdisciplinary Behavioral Program to Improve Access to Preventative Dental Care for Adults With Intellectual and Developmental DisabilitiesJohn C Berens, Loukia Tsami, Dorothea C Lerman, et al.
Preventive Medicine|July 18, 2000
Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testingC Lerman, C Hughes, R T Croyle, et al.
The Pharmacogenomics Journal|August 3, 2011
Gender-stratified gene and gene-treatment interactions in smoking cessationW Lee, A W Bergen, G E Swan, et al.
The Pharmacogenomics Journal|March 10, 2004
The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trialC Lerman, E P Wileyto, F Patterson, et al.
Clinical Pharmacology and Therapeutics|April 5, 2008
Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropionF Patterson, R A Schnoll, E P Wileyto, et al.
Journal of the National Cancer Institute|July 3, 1996
A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testingJ R Botkin, R T Croyle, K R Smith, et al.
Cancer|January 12, 2000
Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Part II: Hereditary nonpolyposis colorectal carcinoma as a modelH T Lynch, P Watson, T G Shaw, et al.
Pageof 25